1. Home
  2. ITOS vs ACCO Comparison

ITOS vs ACCO Comparison

Compare ITOS & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • ACCO
  • Stock Information
  • Founded
  • ITOS 2011
  • ACCO 1893
  • Country
  • ITOS United States
  • ACCO United States
  • Employees
  • ITOS N/A
  • ACCO N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • ACCO Publishing
  • Sector
  • ITOS Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • ITOS 381.2M
  • ACCO 311.7M
  • IPO Year
  • ITOS 2020
  • ACCO N/A
  • Fundamental
  • Price
  • ITOS $10.18
  • ACCO $3.99
  • Analyst Decision
  • ITOS Hold
  • ACCO Buy
  • Analyst Count
  • ITOS 6
  • ACCO 1
  • Target Price
  • ITOS $10.60
  • ACCO $6.00
  • AVG Volume (30 Days)
  • ITOS 911.6K
  • ACCO 850.6K
  • Earning Date
  • ITOS 08-07-2025
  • ACCO 07-31-2025
  • Dividend Yield
  • ITOS N/A
  • ACCO 7.52%
  • EPS Growth
  • ITOS N/A
  • ACCO N/A
  • EPS
  • ITOS N/A
  • ACCO N/A
  • Revenue
  • ITOS $35,000,000.00
  • ACCO $1,624,700,000.00
  • Revenue This Year
  • ITOS N/A
  • ACCO N/A
  • Revenue Next Year
  • ITOS N/A
  • ACCO $0.58
  • P/E Ratio
  • ITOS N/A
  • ACCO N/A
  • Revenue Growth
  • ITOS 177.89
  • ACCO N/A
  • 52 Week Low
  • ITOS $4.80
  • ACCO $3.32
  • 52 Week High
  • ITOS $18.13
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 67.57
  • ACCO 66.15
  • Support Level
  • ITOS $9.95
  • ACCO $3.46
  • Resistance Level
  • ITOS $10.20
  • ACCO $4.00
  • Average True Range (ATR)
  • ITOS 0.15
  • ACCO 0.12
  • MACD
  • ITOS -0.09
  • ACCO 0.06
  • Stochastic Oscillator
  • ITOS 90.00
  • ACCO 91.18

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: